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Unique among mammalian leukocytes, T cells require a dedicated 
organ, the thymus, for differentiation. Postnatal thymic output is 
critical for both effector T cell–mediated immunity1 and regulatory 
T cell–mediated tolerance2. However, there are circumstances (periodic 
infection and aging) that drive the process of severe atrophy known as 
‘thymic involution’, which can result in the loss of more than 95% of the 
cellularity of the thymus. Continued thymic output during such events 
may be detrimental. The theoretical risk posed by continued thymic 
function during an infection is that foreign antigens present in the 
thymus will engender dominant tolerance, protecting the infection from 
clearance3. Thus, thymic involution during infection is a rapid yet tran-
sient phenomenon, with recovery within 1–2 weeks4. Thymic involution 
during aging has also been postulated to have biological functions, from 
acting as a protective mechanism against autoimmunity5 to allowing 
optimization of the peripheral repertoire6 or simply conserving energy 
by diminishing the inefficient process of T cell differentiation during the 
decreasing cost-benefit ratio of old age. The kinetics of thymic involu-
tion during aging are distinct from those of infection-induced thymic 
involution, with a gradual progressive decrease in cellularity, at the rate 
of roughly 1% per year in humans7.
Characterization of the direct mediators of thymic involution 
has identified two distinct pathways for this process. The rapid and 
transient involution initiated during infection can be reproduced by 
exposure to pathogen-associated molecular patterns (PAMPs) such as 
poly(I:C)4. In this system, thymic involution is dependent on the viral 
sensor Mda5 and is mediated by the IFNAR1 receptor for interferon-α 
(IFN-α) expressed on the thymic stroma4. Age-related thymic involu-
tion, in contrast, is mediated by the sensitivity of thymic epithelial 
cells to sex hormones8 and can be reversed by physical or chemical 
ablation of sex hormones9. Other inducers of thymic involution are 
known, ranging from psychological stress to inflammation10,11; how-
ever, these phenomena may instead reflect a maladaptive response 
to noninfectious conditions that mimic signals of infection at the 
molecular level.
Although the main molecular mediators of infection-induced 
thymic involution have been identified, the mechanism by which 
appropriate sensitivity is maintained remains unknown. The thymus 
has conflicting pressures to ensure rapid involution during a high-risk 
infection without undergoing chronic involution due to baseline expo-
sure to PAMPs. One potential regulatory system that would be well 
adapted to tuning involution sensitivity is the microRNA (miRNA) 
network. MicroRNAs are small, noncoding RNAs that modulate the 
production of protein from mRNA through destabilization of the 
mRNA and inhibition of translation. In monocytes and dendritic cells, 
miRNA can tightly regulate the signaling resulting from exposure 
to PAMPs. The miRNA miR-155 is a positive regulator of Toll-like 
receptor signaling and downregulates the signaling inhibitor SOCS1 
and inositol polyphosphate phosphatase SHIP-1 to enhance Toll-like 
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The thymic epithelial microRNA network elevates the 
threshold for infection-associated thymic involution via 
miR-29a mediated suppression of the IFN-a receptor
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Thymic output is a dynamic process, with high activity at birth punctuated by transient periods of involution during infection. 
Interferon-a (IFN-a) is a critical molecular mediator of pathogen-induced thymic involution, yet despite the importance of thymic 
involution, relatively little is known about the molecular integrators that establish sensitivity. Here we found that the microRNA 
network dependent on the endoribonuclease Dicer, and specifically microRNA miR-29a, was critical for diminishing the 
sensitivity of the thymic epithelium to simulated infection signals, protecting the thymus against inappropriate involution. In the 
absence of Dicer or the miR-29a cluster in the thymic epithelium, expression of the IFN-a receptor by the thymic epithelium was 
higher, which allowed suboptimal signals to trigger rapid loss of thymic cellularity.
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receptor signaling12,13. The miRNAs miR-146a, miR-147, miR-125b, 
miR-21 and let-7e, in contrast, are all negative regulators of Toll-like 
receptor signaling and diminish the sensitivity of cells to PAMPs14–17. 
These miRNAs have a complex regulatory system, with both ligand-
dependent enhancement and suppression18. As well as modulating the 
Toll-like receptor signaling pathway, miRNA-146 is also involved in 
the RNA helicase RIG-I antiviral pathway, diminishing the amount 
of the ubiquitin ligase TRAF6 and the kinases IRAK1 and IRAK2 and 
hence modulating IFN-α production19. Therefore, miRNAs are puta-
tive regulators of PAMP signaling in thymic epithelium.
To assess the function of miRNA regulation in thymic function 
and involution, we generated mice with thymic epithelial cell– 
specific deletion of Dicer, the key miRNA-biogenesis protein. We 
found that thymic epithelial cells were exquisitely sensitive to loss of 
the miRNA network, as excision of Dicer drove progressive degenera-
tion of thymic architecture and function, altering T cell differentia-
tion and peripheral tolerance. In addition to the disruption of thymic 
architecture, Dicer-deficient thymic epithelium became hypersensi-
tive to molecular involution signals, which allowed constitutive or 
suboptimal amounts of pathogen-related signals to drive premature 
and chronic thymic involution. This heightened sensitivity was repli-
cated in mice deficient in the miR-29a cluster (miR-29a–miR-29b-1) 
and was associated with loss of miR-29a-dependent regulation of 
IFNAR1. Loss of the miR-29a cluster resulted in IFNAR1-dependent 
hypersensitivity to pathogen-related signals and hyperactivity of the 
IFNAR1 signaling pathway. These results indicate that the miRNA 
network, and miR-29a in particular, is the key threshold modulator of 
the thymic epithelial cell response to peripheral PAMP signals.
RESULTS
Thymic architecture maintained by miRNA
To determine the function of the miRNA network in thymic epithelial 
cells, we used mice with a Foxn1 locus (which encodes a highly spe-
cialized regulator of thymic epithelial cell differentiation) containing 
sequence encoding Cre recombinase knocked into its 3′ untranslated 
region (Foxn1Cre), which produces Cre with high specific activity in 
thymic epithelial cell precursors20, crossed to mice with loxP-flanked 
alleles of Dicer (Dicer1fl/fl; called ‘Dicerfl/fl’ here)21. Histological exam-
ination of epithelial architecture in the thymus of Foxn1CreDicerfl/fl 
mice demonstrated a progressive disruption of thymic architecture. 
Dicer-sufficient siblings (Foxn1+/+Dicerfl/fl mice; called ‘wild-type 
mice’ here) typically had an even distribution of keratin 8–positive 
epithelial cells in the cortex and keratin 14–positive epithelial cells in 
the medulla, with relatively few changes in structure during develop-
ment, beyond expansion of the medulla during the first weeks after 
birth (Fig. 1a). Foxn1CreDicerfl/fl mice developed normal thymic 
architecture, with the presence of a discrete cortex and medulla at 
birth (Fig. 1a). By 1 week of age, however, disorganization of thymic 
structure became apparent, with the loss of homogeneity in keratin 
14 expression and the appearance of regions lacking keratin 14 expres-
sion in the medulla (Fig. 1a). Those keratin 14–negative zones also 
lacked expression of other epithelial markers (Supplementary Fig. 1), 
which suggested the presence of epithelial voids in the medulla. By 
3 weeks of age, large epithelial voids had also opened up in the cortex 
and the medullary epithelium was almost absent. These architectural 
changes were not present in Foxn1CreDicer+/+ mice (Supplementary 
Fig. 2) and were thus due to thymic epithelial cell–specific excision 
of Dicer rather than any cytotoxicity effect of Cre. The heightened 
sensitivity of medullary epithelium to architectural degradation was 
reflected in the cellular composition of the epithelial compartment, 
as measured by flow cytometry (Fig. 1b), whereby the fraction of 
medullary epithelium was much lower than that of the cortical epi-
thelium in Dicer-deficient mice; this created a bias of ~25:1 in the 
ratio of recoverable cortical epithelium to medullary epithelium in 
Foxn1CreDicerfl/fl mice, compared with the normal ratio of ~1:1 in 
wild-type mice (Fig. 1c).
The progressive loss of epithelium from the thymus in 
Foxn1CreDicerfl/fl mice suggested a role for the miRNA network in 
preventing apoptosis of epithelial cells, with medullary epithelium 
showing heightened sensitivity to miRNA loss. In direct support 
of a model of the generation of epithelial voids by more apopto-
sis, costaining of keratin 8 and activated caspase-3 demonstrated 
the presence of apoptotic epithelial cells along the boundary of the 
epithelial voids in Dicer-deficient mice only (Fig. 2a). By staining 
for activated caspase-3, we found significantly more apoptotic epi-
thelium in Foxn1CreDicerfl/fl mice, especially in the medullary com-
partment (Fig. 2b). Despite the greater apoptosis in Dicer-deficient 
epithelium, we found no evidence for selection of Dicer-sufficient 
clones, with Dicer mRNA absent from purified thymic epithelium 
(Supplementary Fig. 3). Corresponding with the higher rate of 
apoptosis, epithelial markers indicative of specialized or terminal 
lineages, such as UEA, Aire, CDR1, claudin 3 and claudin 4, had 
lower expression from birth (Supplementary Figs. 1 and 4 and data 
not shown). In contrast, immature epithelium seemed to be more 
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Figure 1 Loss of miRNA in the thymic epithelium results in progressive 
loss of thymic architecture. (a) Immunofluorescence staining of thymi 
from Foxn1CreDicerfl/fl mice and their wild-type (WT) siblings assessed at 
birth (Neonate) and at 1, 4 and 12 weeks of age: red, keratin 8 (cortex); 
green, keratin 14 (medulla); blue, DNA-intercalating dye DAPI (nuclei). 
Arrows indicate epithelial voids. Scale bars, 100 µm. (b) Frequency of 
cortical epithelium (ctx; BP-1+UEA−) and medullary epithelium (med; 
BP-1−UEA+) in thymi from 12-week-old wild-type and Foxn1CreDicerfl/fl 
mice, measured by flow cytometry and gated on CD45−G8.8+ epithelium. 
Numbers in outlined areas indicate percent UEA+BP-1− cells (top left) or 
UEA−BP-1+ cells (bottom right). (c) Proportion of cortical and medullary 
epithelium (left) and cortical/medullary ratio (C/M; right) in wild-type mice 
(n = 5) and Foxn1CreDicerfl/fl mice (n = 6), analyzed as in b. *P < 0.001 
(t-test). Data are representative of five experiments (a,b) or are pooled 
from five experiments (c; average and s.d.).
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abundant, with more clusters positive for keratin 5 and keratin 8 
and more epithelium positive for the marker p63 (Supplementary 
Fig. 4). The greater proliferation may have been in direct response 
to the higher rate of apoptosis, with a higher percentage of epithe-
lial cells expressing the proliferation marker Ki67, especially in the 
medullary compartment (Fig. 2c). More epithelial turnover, with 
enhanced apoptosis and more compensatory proliferation, would 
account for the skewing of epithelium toward relatively immature 
stages, although the possibility of an additional block in epithelial 
differentiation cannot be excluded.
Given the progressive disintegration of the thymic architecture in 
the absence of Dicer, we assessed whether miRNA contributed to the 
ability of the epithelium to support thymocyte differentiation. Despite 
the large changes in architecture, T cell differentiation remained nota-
bly robust. Early T cell differentiation through rearrangement of the 
T cell antigen receptor and β-selection was intact, with no change in 
the CD4−CD8− (double-negative) or CD4+CD8+ (double-positive) 
thymocyte populations (Supplementary Table 1 and Supplementary 
Fig. 5). At the neonate stage, positive selection was also unmodi-
fied, with relatively normal ratio of double-positive cells to CD4+ or 
CD8+ single-positive cells (Fig. 3a,b). Only after the development of 
large epithelial voids in the thymic cortex at 3 weeks of age did we 
observe notable defects in positive selection, with fewer CD3+CD69+ 
CD4+CD8+ double-positive thymocytes after positive selection 
(Supplementary Table 1 and Supplementary Fig. 5) and CD4+ or 
CD8+ single-positive thymocytes (Fig. 3a,b and Supplementary 
Fig. 5). Functionally, the lower thymic output resulted in a net 
lower abundance of CD4+ T cells and CD8+ T cells in the periphery 
(Supplementary Fig. 6a,b). The combined effects of less T cell pro-
duction and an almost complete loss of medullary thymic epithelial 
cells (Fig. 1c), including Aire-expressing cells (Supplementary Fig. 4), 
produced complex effects on autoimmune susceptibility, with 
Foxn1CreDicerfl/fl mice simultaneously demonstrating a greater sus-
ceptibility to collagen-induced arthritis and a lower severity of disease 
(Supplementary Fig. 6c–e and Supplementary Table 2).
As the phenomena noted above could have been due to fewer inter-
actions with the epithelium, we investigated the cellular composition 
of the epithelial voids further. Although epithelial voids showed an 
absence of thymic epithelium, they were not acellular but had thymo-
cytes present in the cortical voids (Fig. 3c). The distribution of den-
dritic cells and vascularization of epithelial voids was largely normal, 
whereas fibroblasts were absent from cortical voids (Supplementary 
Fig. 7). The frequent distribution of F4/80+ macrophages along the 
boundary of the epithelial voids (Supplementary Fig. 7) further 
supported a model of enhanced epithelial cell death in the region. 
An unusual feature common to the epithelial voids was the presence 
of dense foci of CD19+ B cells, which resulted in an expansion in 
the total number of B cells in the thymus (Fig. 3d,e). These B cells 
may have represented aberrant migration into the thymus or autoch-
thonous production from thymocyte precursors in the absence of epi-
thelial signals. Overall, these results suggested that the Dicer-deficient 
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Figure 2 Enhanced apoptosis of the medullary thymic epithelium in 
the absence of miRNA. (a) Immunofluorescence staining of thymi from 
12-week-old Foxn1CreDicerfl/fl mice and their wild-type siblings. Green, 
keratin 8 (left); red, active caspase-3 (center); yellow, overlay (right). 
Arrows indicate apoptotic epithelial cells. Scale bars, 50 µm. (b,c) 
Proportion of apoptotic cells (cells with activate caspase-3 (Casp3+); b) 
and frequency of proliferating cells (Ki67+ cells; c) in the cortical (BP-
1+UEA−) and medullary (BP-1−UEA+) epithelium of 12-week-old wild-
type mice (n = 4) and their Foxn1CreDicerfl/fl siblings (n = 5), assessed 
by flow cytometry in b. (c) *P < 0.05 and **P < 0.001 (t-test). Data are 
representative of five experiments (a) or are pooled from five experiments 
(b,c; average and s.d.).
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Figure 3 Progressive decay in thymocyte differentiation associated with the presence of epithelial voids in Dicer-deficient mice. (a) Flow cytometry of 
thymocytes from wild-type and Foxn1CreDicerfl/fl thymi. Numbers in outlined areas indicate percent CD4+CD8− (single-positive) cells. (b) Frequency of 
CD4+ single-positive (CD4SP) thymocytes in mice analyzed as in a (n = 2–5 mice per group). (c,d) Immunofluorescence staining of thymi from  
4-week-old Foxn1CreDicerfl/fl mice and their wild-type siblings: red, keratin 14 (c,d); green, CD4 (c) or CD19 (d); blue, DAPI (d). In d, 62% of epithelial 
voids (n = 53) have CD19 foci. Scale bars, 100 µm. (e) Frequency of B cells in thymi from wild-type and Foxn1CreDicerfl/fl siblings (n = 2–5 per group), 
assessed by flow cytometry. *P < 0.05 (t-test). Data are representative of six (a) or three (c,d) experiments or are pooled from five experiments  
(b,e; average and s.d.).
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neonatal thymus had preserved function, but that progressive defects 
in thymocyte differentiation and selection processes developed in line 
with the altered architecture.
miRNAs prevent pathogen-associated thymic involution
Coincident with the thymic architectural changes, Dicer deficiency in 
the thymic epithelium caused premature thymic involution. Although 
thymus size in Foxn1CreDicerfl/fl mice was normal at birth and the 
thymus grew to nearly normal sizes by 4 weeks of age, after that age 
it began to rapidly involute, dropping by 90% at 12 weeks (Fig. 4a). 
To determine if miRNA protects against thymic involution by modu-
lating the sensitivity of the thymic epithelium to sex hormones, we 
surgically castrated Foxn1CreDicerfl/fl mice and their wild-type siblings 
at 7 weeks of age. Although castrated wild-type and Dicer-deficient 
mice demonstrated a gain in thymic cellularity at 12 weeks (Fig. 4b), 
the difference between the two conditions was not eliminated, which 
indicated that the loss of thymic epithelial miRNA did not affect 
sensitivity to a sex-hormone signal.
The second main pathway involved in thymic involution is the 
IFN-α-mediated pathway. By a ‘bioinformatics discovery’ approach, 
IFNAR1 was the only component of the IFN-α signaling pathway 
with higher expression in Dicer-deficient thymic epithelium (S.Z. and 
G.A.H., data not shown). To determine if miRNA regulates sensitiv-
ity of thymic epithelial cells to IFN-α signaling, we purified cortical 
thymic epithelium (BP-1+UEA−) and medullary thymic epithelium 
(BP-1−UEA+) from wild-type and Dicer-deficient mice. In the 
thymus of Dicer-deficient mice, Ifnar1 mRNA was upregulated about 
tenfold in the cortex and about fivefold in the medulla, relative to 
Ifnar1 mRNA expression in the same cell populations from wild-type 
mice (Fig. 4c). IFNAR1 expression on the thymic stroma is criti-
cal for poly(I:C)-mediated thymic involution4, which suggests that 
Dicer deficiency may drive inappropriate thymic involution through 
enhanced sensitivity of thymic epithelial cells to PAMP signals. 
To directly test that hypothesis, we ‘titrated’ poly(I:C) exposure in 
wild-type mice to determine the concentration of poly(I:C) unable 
to induce thymic involution. Doses of 250 µg per mouse and above 
induced thymic involution, whereas doses of 200 µg per mouse and 
below were unable to drive involution in wild-type mice (Fig. 4d). 
Dicer-deficient mice, unlike wild-type mice, were hypersensitive 
to a low dose of poly(I:C) and underwent rapid thymic involution 
when exposed to suboptimal doses of poly(I:C) (Fig. 4e). These data 
demonstrated that the thymic epithelial miRNA network was impor-
tant for protecting the thymus from inappropriate involution at low 
concentrations of PAMPs.
The miR-29a cluster controls thymic involution
A likely miRNA candidate for hypersensitivity to PAMP-mediated 
thymic involution was miR-29a. Among the miRNAs expressed in 
the thymic epithelium (S.Z. and G.A.H., data not shown), miR-29a 
was the miRNA with the highest expression predicted to have multi-
ple interactions with Ifnar1 mRNA (ref. 22). To determine whether 
miR-29a targeted Ifnar1 as predicted, we cloned the 3′ untranslated 
region of Ifnar1 into the 3′ region of a luciferase reporter gene. The 
addition of a miR-29a mimic to HeLa-M human cervical cancer cells 
resulted in the destabilization of mRNA containing the Ifnar 3′ UTR 
region, but the addition of a mimic with scrambled sequence did 
not (Fig. 5a), which demonstrated the specific ability of miR-29a 
to destabilize mRNA containing that region. Because of the poten-
tial redundancy in function of miR-29a, miR-29b and miR-29c, we 
assessed the expression of all three miRNAs by in situ hybridization. 
In the brain, all three miRNAs had high expression (Fig. 5b); how-
ever, in the thymus, we detected only miR-29a in substantial amounts 
(Fig. 5b). The detection of only miR-29a and not miR-29b in the 
thymus, despite cotranscription from the bicistronic miR-29a cluster, 
suggested independent regulation of expression, a feature described 
before for the miR-29a locus, with a 3′ hexanucleotide sequence in 
miR-29b driving nuclear localization and accelerated turnover during 
the nonmitotic portions of the cell cycle23. The in situ data indicating 
lower expression of miR-29b than miR-29a in thymic epithelial cells 
was supported by microarray analysis, whereby miR-29a expression 
was high in the cortex and medulla but miR-29b expression was low 
to undetectable (S.Z. and G.A.H., data not shown), and by quantita-
tive PCR analysis, whereby miR-29a expression was high but miR-29b 
expression was undetectable in half the samples and very low in others 
(Supplementary Fig. 8).
To assess the function of miR-29a in the thymus, we gener-
ated mice with targeted deletion of the miR-29a–miR-29b-1 locus 
(called ‘miR-29a-deficient mice’ here). We removed a region of 
about 1.7 kilobases spanning the entire miR-29a–miR-29b-1 
cluster precursor sequence by homologous recombination 
(Supplementary Fig. 9a) and confirmed the loss of miR-29a–
miR-29b-1 by Southern blot analysis (Supplementary Fig. 9b). 
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In situ hybridization of miR-29a-deficient thymus demonstrated 
complete loss of miR-29a expression without substantial compen-
satory upregulation of miR-29b or miR-29c (Fig. 5b). Our initial 
characterization of these mice indicated no major developmental 
defects, showing birth at a normal Mendelian ratio and no notice-
able abnormalities in major organs such as the brain (Supplementary 
Fig. 10 and Supplementary Table 3).
Analysis of miR-29a-deficient thymus demonstrated that the 
thymic architecture and thymic involution phenotypes of the Dicer-
deficient mice segregated in the miR-29a-deficient mouse. Unlike 
Foxn1CreDicerfl/fl mice, miR-29a-deficient mice demonstrated 
no major changes to thymic architecture, with normal develop-
ment of the cortical and medullary thymic epithelial populations 
and no progressive decay or formation of epithelial voids (Fig. 6 
and Supplementary Figs. 11 and 12). Likewise, thymic function 
seemed intact, with normal differentiation of thymocytes and periph-
eral T cells (Supplementary Fig. 13 and Supplementary Table 4). 
However, miR-29a-deficient mice did undergo premature thymic 
involution after 4 weeks of age (Fig. 6c) at a degree indistinguishable 
from that of Foxn1CreDicerfl/fl mice (Supplementary Fig. 14a,b). As 
with Foxn1CreDicerfl/fl mice, this premature involution was independ-
ent of the amount of sex hormones, as it was not reversed by chemical 
castration (Supplementary Fig. 14c). Unlike the loss of Dicer in 
Foxn1CreDicerfl/fl mice, loss of miR-29a was not restricted to the thymic 
epithelium, which raised the possibility that the same phenotype 
was being generated through alterations in other anatomical com-
partments, such as T cell precursors in the bone marrow. We there-
fore used bone marrow chimeras and thymic transplants to test 
compartmentalization. Wild-type recipients of either miR-29a- 
deficient or wild-type bone marrow had thymi of normal size. 
In contrast, miR-29a-deficient recipients of either miR-29a-deficient 
or wild-type bone marrow had much smaller (90%) thymi (Fig. 6d). 
When we transplanted thymi from neonatal miR-29a-deficient mice 
or their wild-type siblings into wild-type hosts, wild-type thymi 
grafted well and grew in size, whereas miR-29a-deficient thymi 
involuted (Fig. 6e). These results conclusively demonstrated that the 
premature thymic involution observed in miR-29a-deficient mice was 
due to loss of miR-29a in the thymic epithelial compartment and was 
not secondary to changes occurring in other cell types.
The miR-29a cluster suppresses Ifnar1
To determine whether the inappropriate thymic involution in the 
miR-29a-deficient mouse was due to PAMP hypersensitivity, we 
measured Ifnar1 mRNA in purified cortical and medullary epithe-
lium in the preinvolution thymus. As befitting a true direct target, 
Ifnar1 expression was about eightfold higher in miR-29a-deficient 
epithelium than in wild-type epithelium (Fig. 7a), a scale similar 
to that observed in Dicer-deficient epithelium. The higher Ifnar1 
mRNA expression was greater in the medulla after thymic involution 
(Supplementary Fig. 15), suggestive of initiation of a positive feed-
back loop. To directly assess whether this heightened expression reca-
pitulated the Dicer-deficiency phenotype of hypersensitivity to PAMP 
signals, we exposed wild-type and miR-29a-deficient mice to sub-
optimal amounts of poly(I:C). Unlike wild-type mice, but like Dicer-
 deficient mice, miR-29a-deficient mice were hypersensitive to a low 
dose of poly(I:C) and underwent rapid thymic involution (Fig. 7). This 
hypersensitivity was dependent on IFNAR1, as coinjection of antibody 
to IFNAR1 (anti-IFNAR1) restored ~60% of thymic cellularity, but 
coinjection of isotype-matched control antibody did not, in line with 
Figure 5 Ifnar1 is a direct target of miR-29a. (a) Luciferase expression in 
HeLa-M cells (n = 5 replicates per group) transfected with empty renilla 
luciferase reporter plasmid (EV) or plasmid containing the Ifnar1 3′ 
untranslated region (Ifnar1 3′ UTR) and treated with the miR-29a mimic or a 
mimic with scrambled sequence (Scr), presented as relative luciferase units 
(RLU) relative to firefly luciferase. *P < 0.05 (t-test). (b) In situ hybridization 
of miR-29a, miR-29b and miR-29c in the brains of wild-type mice and thymi 
of wild-type or miR-29a-deficient mice (miR-29a-KO): green, miRNA probe; 
blue, DAPI. Scale bars, 100 µm. Data are representative of three independent 
experiments (a; error bars, s.d.) or two experiments (b).
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Figure 6 Thymic involution and architectural 
alterations segregate in miR-29a-deficient mice. 
(a,b) Immunofluorescence staining of thymi from 
wild-type and miR-29a-deficient mice assessed 
at 1, 6 and 10 weeks of age: red, UEA (a) or 
keratin 14 (b); green, keratin 14 (a) or G8.8 
(EPCAM; b). Scale bars, 100 µm. (c) Thymic 
cellularity of wild-type and miR-29a-deficient 
mice (n = 2–7 per group) at birth and at 4, 9,  
10 and 12 weeks of age. (d) Thymic cellularity 
of chimeras generated by the transfer of wild-
type or miR-29a-deficient bone marrow into 
wild-type or miR-29a-deficient recipient mice 
(n = 4–13 per group). (e) Thymic cellularity of 
wild-type mice given transplantation of wild-type 
thymus (n = 3) or miR-29a-deficient thymus  
(n = 4), assessed at 6 weeks after transplantation. 
*P < 0.05 and **P < 0.0001 (t-test). Data 
are representative of five experiments (a,b) or 
are pooled from five experiments (c) or three 
experiments (d,e; error bars (c–e), s.d.).
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the neutralization capacity of ~60% for this antibody24. The ability of 
miR-29a-deficient mice to recover from poly(I:C) seemed intact, with 
~50% cellular recovery 10 d after treatment (Supplementary Fig. 16). 
Even when not treated with a low dose of poly(I:C), by 12 weeks 
of age miR-29a-deficient mice had more phosphorylation of STAT1, 
the direct downstream target of IFNAR1, evidence that the greater 
abundance of Ifnar1 mRNA had a biologically relevant effect. 
Together these results demonstrated that loss of miR-29a in the thymic 
stroma resulted in premature thymic involution and hypersensitivity 
to pathogen-associated signals, indistinguishable from complete loss 
of the miRNA network in thymic epithelium.
DISCUSSION
The role of miRNA in the adaptive immune system has been inves-
tigated through systematic removal of the miRNA network in 
T cells25,26, B cells27 and key accessory cell lineages such as dendritic 
cells28. Although many functions of the adaptive immune system 
seem to be independent of the miRNA network, several key aspects 
are under tight miRNA-mediated control, including stability of the 
regulatory T cell lineage29, immunoglobulin repertoire generation27 
and PAMP responsiveness28. One of the main accessory cell types in 
the adaptive immune system whose miRNA function has not yet been 
profiled is the thymic epithelial cell. Here we used conditional deletion 
of Dicer to show that loss of the miRNA network in thymic epithelial 
cells led to decay of the epithelial architecture, less thymocyte posi-
tive selection, an enhanced B cell presence, greater susceptibility to 
induced autoimmunity and inappropriate chronic thymic involution. 
This diverse array of phenotypes can be explained by the following 
two distinct cellular processes: first, an miR-29a-independent increase 
in epithelial cell apoptosis, which gives a parsimonious account for 
most of the phenotypes observed; and second, miR-29a-dependent 
sensitivity to thymic involution.
The root driver of the miR-29a-independent phenotypes was prob-
ably changes in thymic architecture. The progressive loss of thymic 
epithelium was the first phenotype to appear, chronologically, with epi-
thelial voids apparent by 1 week of age. It is likely that these epithelial 
voids were formed by enhanced rates of apoptosis in Dicer-deficient 
epithelium, with the enhanced epithelial cell proliferation and imma-
ture cells suggestive of a compensatory process. Two separate expla-
nations can be postulated for why the enhanced apoptosis resulted 
in epithelial voids rather than a generalized lower epithelial density 
across the thymus. First, the death may have been synchronized among 
expanses of the thymus populated by clonal epithelial cells30, where 
intrinsic sensitivity could create a large void through synchronous 
death. Second, the epithelial void may have progressively formed 
because of extrinsic effects resulting from localization along the void 
boundary. As thymic epithelial cells are very much reliant on the three-
dimensional network31,32, loss of interactions at the edge of the void 
may be sufficient to elicit apoptosis. Alternatively, proliferation of cells 
at the edge of the void in compensation may place them at a greater 
risk of apoptosis, as Dicer-deficient cells are especially vulnerable to 
apoptosis during proliferation33. The presence of apoptotic epithelial 
cells along the void perimeter may support the second explanation but 
does not rule out the first. The reason for the chronological primacy 
in void formation in the medulla remains an open question, but it may 
reflect enhanced sensitivity to one of the models described above.
The remaining thymic phenotypes can be explained as secondary 
effects resulting from the primary decay in thymic architecture. We 
did not observe the defects in positive selection and the greater B 
cell numbers in mice before 4 weeks of age, which suggested that 
these changes resulted not from abnormal regulation of key epithelial 
proteins but instead from the ‘anatomical traps’ formed by epithelial 
cell decay. Early thymocytes precursors that enter the thymus 
and find themselves in the absence of expression of ligand for the 
receptor Notch by thymic epithelial cells may default into B cell differ-
entiation34,35. Likewise, double-positive thymocytes that migrate into 
epithelial cell voids would have less interaction with cortical epithelial 
cells, which would probably result in less positive selection. It is nota-
ble that the defect in positive selection is observed solely in the lineage 
differentiating into CD4+ single-positive cells, as CD8+ single-positive 
selection can occur with less efficiency through interaction with 
non-epithelial cells36. The finding of greater susceptibility of Dicer- 
deficient mice to autoimmunity was also supported by the ‘anatomical 
trap’ model, as single-positive thymocytes in Dicer-deficient mice have 
very low exposure to medullary epithelium and Aire+ epithelial cells 
for efficient negative selection. The progressive decay observed here 
is probably not amenable to delineation to a single miRNA or mRNA 
target. Although individual miRNAs have been shown to induce 
apoptosis18 or suppress apoptosis37, the observation of enhanced apop-
tosis in Dicer-deficient cell types of diverse origin27,38,39 suggests that 
this is an emergent feature of regulatory disruption of the whole- 
network deletion achieved by excision of Dicer.
In contrast, the most striking feature of the Dicer-deficient thymus, 
inappropriate chronic involution, can be accounted for by a single 
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Figure 7 Thymic epithelial defects in miR-29a result in PAMP 
hypersensitivity and inappropriate thymic involution. (a) Ifnar1 mRNA 
expression in cortical (BP-1+UEA−) and medullary (BP-1−UEA+) thymic 
epithelium from 6- to 8-week-old wild-type mice (n = 5) and miR-29a-
deficient mice (n = 3), presented relative to values for wild-type cortex. 
(b) Thymic cellularity of 4-week-old wild-type and miR-29a-deficient mice 
(n = 3–10 per group) left untreated or treated with 150 µg poly(I:C) at 
4 weeks, with or without coinjection of anti-IFNAR1 or isotype-matched 
control antibody (Isotype). (c) Immunofluorescence staining of thymi 
from 12-week-old wild-type and miR-29a-deficient mice: green, keratin 
8 (left); red, phosphorylated (p-) STAT1 (center); yellow, colocalization 
(right). Scale bars, 100 µm. *P < 0.05 and **P < 0.0001 (t-test).  
NS, not significant. Data are pooled from three experiments (a,b) or are 
representative of two experiments (c; error bars (a,b), s.d.).
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miRNA-mRNA interaction. It is notable that both Dicer-deficient 
and miR-29a-deficient thymi developed to a normal size at birth and 
expanded during growth to 4 weeks before collapsing in size between 9 
and 12 weeks of age. That observation indicates that the phenomenon 
was involution and not a failure in thymic growth. The inappropriate 
involution caused by loss of miR-29a expression can be explained by 
the loss of tight regulation of IFNAR1 expression. We demonstrated 
here that ifnar1 was a true target of miR-29a and that expression 
of IFNAR1 was upregulated in thymic epithelium after the loss of 
Dicer or miR-29a. Furthermore, IFNAR1 upregulation enhanced 
the sensitivity of the thymic epithelium to PAMP signals, driving 
thymic involution at suboptimal PAMP exposure. The spontaneous 
thymic involution in older miR-29a-deficient mice was accompanied 
by activation of STAT1, and thus greater sensitivity to baseline IFN-α 
is the parsimonious explanation for the observed chronic involution. 
In this model, miR-29a has a key role in the thymic epithelium in 
limiting IFNAR1 expression and hence diminishing the threshold 
at which thymic epithelial cells become triggered to undergo involu-
tion. In the absence of epithelial miRNA, baseline PAMP exposure 
is sufficient to trigger the chronic involution observed. In contrast, 
in the presence of epithelial miRNA, the thymus is buffered against 
small amounts of IFN-α, which permits involution to be triggered 
only after an adequate infectious trigger. The published observation 
that exposure to both IFN-α and PAMPs drives the downregulation 
of Dicer40 raises the possibility that positive feedback loops may be 
induced by pathogen exposure, whereby the amounts of IFN-α suffi-
cient to drive Dicer downregulation result in upregulation of IFNAR1, 
initiating the involution cascade.
METHODS
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
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ONLINE METHODS
Mice. Foxn1cre mice41 were intercrossed with Dicerfl mice21 to produce mice 
on the C57BL/6 background with excision of Dicer specific to thymic epithelial 
cells. The miR-29a-deficient mice were generated as described below. Mice were 
chemically castrated at 4 months of age by intramuscular injection of 0.4 mg 
leuprorelin acetate (Lupron), followed by analysis at 6 months of age. 
Mice were surgically castrated at 7 weeks of age and assessed at 12 weeks of age9. 
Bone marrow chimeras were generated by injection of bone marrow (1 × 106 
cells per recipient) treated with complement (Low-Tox M Rabbit Complement; 
Cedarlane) into irradiated host mice (9.5 Gy). Neonatal thymus was trans-
plantated under the kidney capsule at 6 weeks of age under sterile conditions. 
High-molecular-weight poly(I:C) (Invivogen) was injected intraperitoneally on 
days 0 and 3, with cellularity measured on day 4. In neutralization experiments, 
0.75 mg anti-IFNAR1 (MAR1-5A3; Biolegend) or isotype-matched control anti-
body (GIR-208; Biolegend) was injected intravenously on days 0 and 3 at 1 h 
before treatment with poly(I:C). Histology was done by Histology Consultation 
Services and pathology reports were generated by BioGenetics. Mice were housed 
under specific pathogen–free conditions and were used in accordance with the 
University of Leuven Animal Ethics Committee.
Generation of miR-29a-deficient mice. Bacterial artificial chromosome 
clone RPCIB731L15459Q2 was used as the source for the 10.9-kilobase 
region surrounding the miR-29a–miR-29b-1 gene. A 1.7-kilobase region 
between the 5′ Afel site and the 3′ Sal1 site was deleted by the introduction 
of a gene encoding hygromycin resistance, and the linearized pBluescript II 
KSM vector was transfected by electroporation into E14 129/Ola mouse 
embryonic stem cells. Clones that underwent homologous recombina-
tion events were identified by hygromycin selection and were screened by 
Southern blot analysis. Genomic DNA was digested with EcoRI, EcoRV 
or NcoI and was hybridized to a genomic DNA external 5′ probe (PCR 
product with primers 5′-ACCCTGACATTGACACAGC-3′ (forward) and 
5′-AAAGGGGTCTTAGCATCCA-3′ (reverse)) and 3′probe (PCR prod-
uct with primers 5′-CTAGAGCCAAGGATAGCTGTGT-3′ (forward) and 
5′-CCTTCATGAGCGTGTAAGACA-3′ (reverse)) and an internal hygromycin 
DNA probe (PCR product with primers 5′-CAGCGAGAGCCTGACCTATT 
GC-3′ (forward) and 5′-CGATCCTGCAAGCTCCGGATG-3′ (reverse)). 
Embryonic stem cell clones were microinjected into C57BL/6 bastocysts 
for the generation of chimeras. The chimeras then were backcrossed to 
C57BL/6 mice for more than seven generations. Mice deficient in miR-29a 
were genotyped by PCR with primers for the wild-type band (561 base 
pairs; 5′-CTTAATTCTTACCTGTGGCTCCAACG-3′ (forward) and 
5′-GAACTATTGCACGGACTTCACCTTCC-3′ (reverse)) and knockout 
band (717 base pairs; 5′-AAATGGTTCAAACGCTCCAC-3′ (forward) and 
5′-CAGAAAGCGAAGGAGCAAAG -3′ (reverse)).
Arthritis induction. Collagen-induced arthritis was induced by intradermal 
injection of chicken collagen type II (Sigma-Aldrich) in Freund’s complete 
adjuvant, as described42. Clinical severity of disease was monitored for 40 d 
after induction with a published scoring system43. Susceptibility to arthritis 
was assessed as the incidence of arthritis at completion, with four independent 
groups (two male and two female) treated as paired values in a two-tailed t-test. 
Arthritis severity among affected mice showed no substantial difference across 
sex or replicates; thus, groups were merged and differences in severity were 
tested with unpaired t-tests for each time point and maximum disease score.
Flow cytometry and immunofluorescence. Mice were analyzed with the follow-
ing antibodies: fluorescein isothiocyanate–conjugated anti-CD69 (H1.2F3; eBio-
science), anti-CD25 (IL-2Rα; p55; eBioscience), anti-IgM (11/41; eBioscience) 
and Ulex Europaeus Agglutinin (Vector Labs); phycoerythrin-conjugated 
anti-CD8 (53.6.7), anti-CD19 (1D3) and anti-BP-1 (6C3; all from eBioscience); 
peridinin chlorophyll protein–conjugated anti-CD3 (145-2C11; eBioscience) and 
anti-B220 (RA3-6B2; eBioscience); allophycocyanin-conjugated anti-Foxp3 (FJK-
16s; eBioscience), anti-CD44 (1M7; eBioscience), anti-CD45 (104; eBioscience), 
anti-CD43 (eBioR2/60; eBioscience) and anti-Ki67 (B56; BD Pharmingen); 
phycoerythrin-indotricarbocyanine-conjugated anti-CD4 (RM4-5; eBioscience), 
anti-CD23 (B3B4; eBioscience) and anti-EPCAM (G8.8; Biolegend); biotin-
conjugated antibody to active caspase-3 (550557; BD Pharmingen), followed 
by streptavidin–Alexa Fluor 647; and phycoerythrin–cyanine 5.5–conjugated 
antibody to I-A–I-E (M5/114.15.2; Biolegend). Intracellular staining was done 
after cells were fixed and made permeable with reagents from the eBiosciences 
Foxp3 staining kit.
Thymus sections were prepared and stained as described44. Brain tissues were 
fixed in 4% (vol/vol) paraformaldehyde, made permeable in 0.25% (vol/vol) 
Triton-X100 and blocked with 1% Blocking Reagent (Roche) in 0.2% (vol/vol) 
FCS. Sections were stained with monoclonal antibody to keratin 8(Troma-1; 
Developmental Studies Hybridoma Bank), anti-meca-32 (Meca-32; in-house 
supernatant), anti-CD4 (GK1.5; in-house supernatant), anti-CD8 (2.43; 
in-house supernatant), anti-D19 (1D3; in-house supernatant), anti-Epcam 
(G8.8; in-house supernatant), anti-Emr1 (F4/80, in-house supernatant), anti-
CD11c (N418; eBioscience), anti-ERTR7 (ERTR7; in-house supernatant) 
and anti-NeuN (A60; Millipore); and polyclonal antibody to keratin 5 (PRB-
160P; Covance), antibody to keratin 14 (PRB-115P-100; Covance), anti-Aire 
(D-17; Santa Cruz), anti-p63 (poly6190; Biolegend), antibody to STAT1 phos-
phorylated at Ser727 (S727; Cell Signaling Technology) and Ulex Europaeus 
Agglutinin (Vector Laboratories). For immunofluorescence, the following 
detection antibodies were used: Alexa Fluor 594–goat anti-mouse (A-11005; 
Invitrogen), Alexa Fluor 488–donkey anti-rat (A21208; Molecular Probes), 
Alexa Fluor 488–donkey anti-rabbit (A21206; Molecular Probes), Alexa Fluor 
546–donkey anti-goat (A11056; Molecular Probes), Alexa Fluor 555–donkey 
anti-rabbit (A31572; Molecular Probes), Alexa Fluor 647–chicken anti-rat 
(A21472; Molecular Probes), streptavidin–Alexa Fluor 488 (S32354; Molecular 
Probes) and streptavidin–Alexa Fluor 546 (S11225; Molecular Probes). Images 
were acquired with an LSM 510 Meta confocal microscope (Ziess).
In situ hybridization. In situ hybridization of miR-29 was done as described45. 
Locked nucleic acid probes with 2′O-methyl modifications were used for 
hybridization to miRNA. Fresh frozen thymus sections 10 µm in thickness 
were thawed and dried and fixed for 10 min with 4% (vol/vol) paraformalde-
hyde. After being washed, slides were briefly sunk into acetic anhydrite–TEA 
solution and washed, followed by prehybridization for 1 h, then hybridiza-
tion for 30 min. Washes of various stringencies followed, then incubation 
with 3% (vol/vol) H2O2. After slides were washed and blocked, horseradish 
peroxidase–conjugated antibody to fluorescein isothiocyanate (B13-DE1; 
Roche) was applied to the slides and signals were amplified after appropriate 
washing with the TSA system (PerkinElmer). Sections were mounted with 
Prolong Gold Antifade reagent (Invitrogen).
Luciferase assay. The Ifnar1 3′ untranslated region was amplified from 
genomic DNA, inserted into the PsiCheck2 renilla luciferase reporter 
plasmid (Promega) and confirmed by sequencing. For reporter assays, 
HeLa-M cells were cotransfected in triplicate through the use of Lipofectamine 
2000 (Invitrogen) with empty PsiCheck2 or PsiCheck2 containing the Ifnar1 
3′UTR in conjunction with either mouse miR-29a mimic or a mimic con-
trol with scrambled sequence (Dharmacon) at a final concentration of 
40 nM. Firefly luciferase was used as a normalization control. Reporter activity 
was detected 24 h after transfection with the Dual-Glo Luciferase Assay 
System (Promega).
Thymic epithelial expression analysis. Thymic stroma preparations were 
enriched from three to six pooled thymi46. Cells were stained with fluo-
rescein isothiocyanate–conjugated Ulex Europaeus Agglutinin (Vector 
Labs), phycoerythrin-conjugated anti-BP-1 (6C3; eBioscience), peridinin 
chlorophyll protein–cyanine 5.5–conjugated anti–I-A–I-E (M5/114; 
Biolegend), allophycocyanin-conjugated anti-CD45 (104; eBiosciences) 
and phycoerythrin-indotricarbocyanine-conjugated anti-Epcam (G8.8; 
Biolegend) and were sorted into cortical epithelium (CD45−MHCII+G8.8+ 
BP-1+UEA−, where ‘MHCII’ indicates major histocompatibility complex 
class II) and medullary epithelium (CD45−MHCII+G8.8+BP-1−UEA+). Total 
RNA was isolated with a miRVana PARIS kit (Ambion), and cDNA was pro-
duced with a High Capacity cDNA Reverse Transcription Kit according to 
the manufacturer’s protocol (Applied Biosystems). A Roche LightCycler 480 
Sequence Detector based on SYBR green I fluorescence (qPCR MasterMix 
Plus for SYBR Green I; Eurogentec) was used for quantitative RT-PCR, fol-
lowed by analysis by the change-in-threshold method (2−∆∆CT)47. All mRNA 
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values were normalized to Actb mRNA (encoding β-actin); miRNA results 
were normalized to those of the housekeeping small RNA RNU19.
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